The expression of TOX2 in the AML-CR group was higher than that in the HI group (median: 2.45 vs. 2.00, P = 0.016); however, the expression of TOX3 was lower than that in the HI group (1.53 vs. 1.97, P = 0.016). Here, TOX2 is linked to acute myeloid leukemia.